Gadopentetate Dimeglumine

Records for this ingredient, by country (identity only).

ATC V08CA01 · 3 markets · 13 records

Gadopentetate Dimeglumine 3 markets · 13 records Forms
Filters
MarketAU 8TW 2CA 1

AU 8 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 469.01 mg/mL per mL / per unit basis not statedinjectionMAGNEVIST gadopentetate dimeglumine 4.69g/10mL injection vialMAGNEVIST gadopentetate dimeglumine 46.9g/100mL injection bottle、MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection syringe unknown

TW 2 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Gadomni I.V. Injection ×1MAGNEVIST ×1嘉多明造影靜脈注射劑 ×1美格維斯造影注射液 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 469 mg per mL / per unit basis not statedliquidMAGNEVIST

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.